171 related articles for article (PubMed ID: 19709357)
1. The cardiac biomarker NT-proBNP is increased in dogs with azotemia.
Raffan E; Loureiro J; Dukes-McEwan J; Fonfara S; James R; Swift S; Bexfield N; Herrtage ME; Archer J
J Vet Intern Med; 2009; 23(6):1184-9. PubMed ID: 19709357
[TBL] [Abstract][Full Text] [Related]
2. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
Schmidt MK; Reynolds CA; Estrada AH; Prosek R; Maisenbacher HW; Sleeper MM; Oyama MA
J Vet Cardiol; 2009 May; 11 Suppl 1():S81-6. PubMed ID: 19394913
[TBL] [Abstract][Full Text] [Related]
3. Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.
Miyagawa Y; Tominaga Y; Toda N; Takemura N
Vet J; 2013 Aug; 197(2):445-50. PubMed ID: 23570775
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.
Pelander L; Häggström J; Ley CJ; Ljungvall I
J Vet Intern Med; 2017 May; 31(3):805-813. PubMed ID: 28370332
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
Ettinger SJ; Farace G; Forney SD; Frye M; Beardow A
J Am Vet Med Assoc; 2012 Jan; 240(2):171-80. PubMed ID: 22217025
[TBL] [Abstract][Full Text] [Related]
6. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
Haßdenteufel E; Kresken JG; Henrich E; Hildebrandt N; Schneider C; Stosic A; Schneider M
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):171-9. PubMed ID: 22688794
[TBL] [Abstract][Full Text] [Related]
7. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
Fox PR; Oyama MA; Hezzell MJ; Rush JE; Nguyenba TP; DeFrancesco TC; Lehmkuhl LB; Kellihan HB; Bulmer B; Gordon SG; Cunningham SM; MacGregor J; Stepien RL; Lefbom B; Adin D; Lamb K
J Vet Intern Med; 2015 Jan; 29(1):171-9. PubMed ID: 25308881
[TBL] [Abstract][Full Text] [Related]
8. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
9. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
Fine DM; DeClue AE; Reinero CR
J Am Vet Med Assoc; 2008 Jun; 232(11):1674-9. PubMed ID: 18518809
[TBL] [Abstract][Full Text] [Related]
11. Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.
Couto KM; Iazbik MC; Marín LM; Zaldivar-López S; Beal MJ; Gómez Ochoa P; Couto CG
Vet Clin Pathol; 2015 Sep; 44(3):405-9. PubMed ID: 25982692
[TBL] [Abstract][Full Text] [Related]
12. [Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases].
Wei BQ; Zhang J; Yang YJ; Zhang YH; Huang XH; Yu LT; Zhou Q; Tan HQ; Yang YM; Wang GG; Zhu J
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(38):2683-7. PubMed ID: 22321977
[TBL] [Abstract][Full Text] [Related]
13. Renal resistive index in 55 dogs with degenerative mitral valve disease.
Chetboul V; Daste T; Gouni V; Concordet D; Trehiou-Sechi E; Serres F; Pouchelon JL; Germain CA; Layssol-Lamour C; Lefebvre HP
J Vet Intern Med; 2012; 26(1):101-8. PubMed ID: 22111692
[TBL] [Abstract][Full Text] [Related]
14. Plasma N-terminal pro-brain natriuretic peptide concentrations before and after pericardiocentesis in dogs with cardiac tamponade secondary to spontaneous pericardial effusion.
Baumwart RD; Hanzlicek AS; Lyon SD; Lee PM
J Vet Cardiol; 2017 Oct; 19(5):416-420. PubMed ID: 28988688
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
Wolf J; Gerlach N; Weber K; Klima A; Wess G
Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency.
Takemura N; Toda N; Miyagawa Y; Asano K; Tejima K; Kanno N; Arisawa K; Kurita T; Nunokawa K; Hirakawa A; Tanaka S; Hirose H
J Vet Med Sci; 2009 Jul; 71(7):925-9. PubMed ID: 19652480
[TBL] [Abstract][Full Text] [Related]
17. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
Oyama MA; Rush JE; Rozanski EA; Fox PR; Reynolds CA; Gordon SG; Bulmer BJ; Lefbom BK; Brown BA; Lehmkuhl LB; Prosek R; Lesser MB; Kraus MS; Bossbaly MJ; Rapoport GS; Boileau JS
J Am Vet Med Assoc; 2009 Dec; 235(11):1319-25. PubMed ID: 19951101
[TBL] [Abstract][Full Text] [Related]
18. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
19. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
Kanno N; Hori Y; Hidaka Y; Chikazawa S; Kanai K; Hoshi F; Itoh N
J Vet Med Sci; 2016 May; 78(4):535-42. PubMed ID: 26607133
[TBL] [Abstract][Full Text] [Related]
20. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
Hezzell MJ; Block CL; Laughlin DS; Oyama MA
J Vet Intern Med; 2018 Sep; 32(5):1509-1516. PubMed ID: 30216549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
